Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.

Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
复制标题

DOI:
10.18632/oncotarget.3244
复制
发表时间:
2015-03-10
期刊:
影响因子:
--
通讯作者:
Nomura F
Nomura F
中科院分区:
其他
文献类型:
--
作者:
Matsushita K;Kitamura K;Rahmutulla B;Tanaka N;Ishige T;Satoh M;Hoshino T;Miyagi S;Mori T;Itoga S;Shimada H;Tomonaga T;Kito M;Nakajima-Takagi Y;Kubo S;Nakaseko C;Hatano M;Miki T;Matsuo M;Fukuyo M;Kaneda A;Iwama A;Nomura F

文献摘要

参考文献

被引文献

相似文献

FUSE结合蛋白(FBP)相互作用阻遏物(FIR)是一种c-myc转录抑制因子。在转录抑制子结构域中缺少外显子2的FIR剪接变体(FIRΔ exon 2)通过使野生型FIR失活而上调c-myc转录。大肠癌和肝细胞癌组织中FIRΔ exon 2/FIR mRNA比值升高。因为FIRΔ外显子2被认为是FIR的显性负调控因子,所以产生FIR杂合敲除(FIR+/-)C57 BL 6小鼠。FIR完全敲除(FIR-/-)在E9.5之前是胚胎致死的;因此,它对胚胎发生是必需的。这有力地表明,FIR不足是至关重要的致癌作用。FIR+/-小鼠表现出显著的c-myc mRNA上调,特别是在外周血(PB)中,没有任何显著的致病表型。此外,在人白血病样品和细胞系中检测到FIRΔ exon 2/FIR mRNA表达升高。由于TP 53的单一敲除产生胸腺淋巴瘤,FIR+/-TP 53-/-产生T细胞型急性淋巴细胞/淋巴母细胞白血病(T-ALL),器官或骨髓浸润增加,预后不良。分选的胸腺淋巴瘤细胞的RNA测序分析显示,与FIR+/+ TP 53 −/−小鼠相比,FIR +/− TP 53 −/−小鼠的Notch信号通路被显著激活。使用qRT-PCR确认分选的胸腺淋巴瘤细胞中的Notch 1 mRNA表达。流式细胞仪检测显示,在分选的T-ALL/胸腺淋巴瘤细胞中,c-myc mRNA与FIR呈负相关,而与Notch 1呈正相关。此外,使用siRNA敲低TP 53或c-myc降低了癌细胞中Notch 1的表达。此外,编码FIRΔ exon 2 cDNA的腺病毒载体增加博莱霉素诱导的DNA损伤。综上所述,这些数据表明FIRΔ外显子2的表达改变至少部分地通过TP 53非依赖性途径激活c-Myc来增加Notch 1。总之,FIR的选择性剪接,产生FIRΔ外显子2,可能有助于结直肠癌和白血病的发生。
FUSE-binding protein (FBP)-interacting repressor (FIR) is a c-myc transcriptional suppressor. A splice variant of FIR that lacks exon 2 in the transcriptional repressor domain (FIRΔexon2) upregulates c-myc transcription by inactivating wild-type FIR. The ratio of FIRΔexon2/FIR mRNA was increased in human colorectal cancer and hepatocellular carcinoma tissues. Because FIRΔexon2 is considered to be a dominant negative regulator of FIR, FIR heterozygous knockout (FIR+/−) C57BL6 mice were generated. FIR complete knockout (FIR−/−) was embryonic lethal before E9.5; therefore, it is essential for embryogenesis. This strongly suggests that insufficiency of FIR is crucial for carcinogenesis. FIR+/− mice exhibited prominent c-myc mRNA upregulation, particularly in the peripheral blood (PB), without any significant pathogenic phenotype. Furthermore, elevated FIRΔexon2/FIR mRNA expression was detected in human leukemia samples and cell lines. Because the single knockout of TP53 generates thymic lymphoma, FIR+/−TP53−/− generated T-cell type acute lymphocytic/lymphoblastic leukemia (T-ALL) with increased organ or bone marrow invasion with poor prognosis. RNA-sequencing analysis of sorted thymic lymphoma cells revealed that the Notch signaling pathway was activated significantly in FIR+/−TP53−/− compared with that in FIR+/+TP53−/− mice. Notch1 mRNA expression in sorted thymic lymphoma cells was confirmed using qRT-PCR. In addition, flow cytometry revealed that c-myc mRNA was negatively correlated with FIR but positively correlated with Notch1 in sorted T-ALL/thymic lymphoma cells. Moreover, the knockdown of TP53 or c-myc using siRNA decreased Notch1 expression in cancer cells. In addition, an adenovirus vector encoding FIRΔexon2 cDNA increased bleomycin-induced DNA damage. Taken together, these data suggest that the altered expression of FIRΔexon2 increased Notch1 at least partially by activating c-Myc via a TP53-independent pathway. In conclusion, the alternative splicing of FIR, which generates FIRΔexon2, may contribute to both colorectal carcinogenesis and leukemogenesis.
转录依赖性动态超串联是一种短距离基因组力。
DOI: 10.1038/nsmb.2517
发表时间: 2013-03
影响因子: 16.8
作者:
Kouzine, Fedor;Gupta, Ashutosh;Baranello, Laura;Wojtowicz, Damian;Ben-Aissa, Khadija;Liu, Juhong;Przytycka, Teresa M.;Levens, David
通讯作者: Levens, David
DOI: 10.1021/bi9021445
发表时间: 2010-06-08
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
Hsiao, Hsin-hao;Nath, Abhinav;Braddock, Demetrios T.
通讯作者: Braddock, Demetrios T.
DOI: 10.1158/0008-5472.can-04-4459
发表时间: 2006-02-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Matsushita, K;Tomonaga, T;Ochiai, T
通讯作者: Ochiai, T
DOI: 10.1016/j.molcel.2007.02.022
发表时间: 2007-04-13
期刊: MOLECULAR CELL
影响因子: 16
作者:
Hao, Bing;Oehlmann, Stephanie;Pavletich, Nikola P.
通讯作者: Pavletich, Nikola P.
DOI: 10.1182/blood-2012-09-399725
发表时间: 2013-01-10
期刊: BLOOD
影响因子: 20.3
作者:
Cazzola, Mario;Rossi, Marianna;Malcovati, Luca
通讯作者: Malcovati, Luca